Zika Pandemic May Push U.S. to Approve Intrexon's (XON) OX513A - Griffin Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Intrexon (XON), Inovio Pharma (INO) Moving Back to Highs on Zika Outbreak
January 28, 2016 11:08 AM ESTAfter consolidating this morning's move higher, Intrexon (NYSE: XON) and Inovio Pharma (NASDAQ: INO) are moving to the highs following the continued Zika outbreak which the WHO said is "spreading explosively."
... MorePre-Open Stock Movers 01/28: (NEOS) (UA) (FB) Higher; (NOW) (OSIS) (EBAY) Lower (more...)
January 28, 2016 9:30 AM ESTNeos Therapeutics (NASDAQ: NEOS) 59% HIGHER; the U.S. Food and Drug Administration (FDA) approved Adzenys... More
Intrexon (XON), Inovio Pharma (INO) on Watch as Zika Virus 'Spreading Explosively'
January 28, 2016 8:19 AM ESTInovio Pharma (NASDAQ: INO) and Intrexon (NYSE: XON) are on watch on reports the Zika virus is "spreading explosively."
The Zika virus is strongly suspected of causing birth defects and may infect 3-4 million people in the Americas, including 1.5 million in Brazil, a World Health Organization expert said on Thursday.
... More